AAMU
WVE icon

Amundi Asset Management US’s Wave Life Sciences WVE Stock Holding History

Amundi Asset Management US’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,900
Closed -$122 – 1688
2018
Q4 		$122 Buy
2,900
+900
+45% +$40K ﹤0.01% 1477
2018
Q3 		$100K Buy
+2,000
New +$90.2K ﹤0.01% 1518

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Amundi Asset Management US's WVE Position: Q1 2019 in Review

Amundi Asset Management US sold out of Wave Life Sciences (WVE) in Q1 2019, closing a stake of 2,900 shares — an estimated $122 sold.

Amundi Asset Management US first reported a position in WVE in Q3 2018 and held it in 2 quarters. The position peaked at $100K in Q3 2018. 110 funds tracked by Wall St. Rank hold WVE as of Q1 2019.

  • Amundi Asset Management US reported no remaining Wave Life Sciences position as of Q1 2019 after selling out during the quarter.
  • Amundi Asset Management US sold 2,900 Wave Life Sciences shares in Q1 2019, an estimated $122.
  • Amundi Asset Management US first reported a position in Wave Life Sciences in Q3 2018 and held it in 2 quarters.
  • Amundi Asset Management US's Wave Life Sciences position peaked at $100K in Q3 2018.
  • 110 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2019.

Based on Amundi Asset Management US's 13F filing for Q1 2019, filed 13 May 2019.